Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) traded down 17.2% on Monday . The stock traded as low as C$0.12 and last traded at C$0.12. Approximately 148,069 shares traded hands during mid-day trading, an increase of 155% from the average session volume of 58,055 shares. The stock had previously closed at C$0.14.
Nanalysis Scientific Stock Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.10 and a current ratio of 1.42. The company has a market capitalization of C$16.61 million, a P/E ratio of -2.40 and a beta of -0.48. The business has a 50 day moving average of C$0.13 and a 200-day moving average of C$0.14.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Further Reading
- Five stocks we like better than Nanalysis Scientific
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
- If Boeing Ramps Up Production, These Suppliers May Win Big
- Marvell Takes a Shot a Broadcom’s Throne With Google Deal
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
